<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="LIRI-JP_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002155">
		<TITLE>ICGC PCAWG Dataset: LIRI-JP_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: LIRI-JP.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001229871"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229639"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229819"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229875"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229931"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229679"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229546"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229531"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229456"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229942"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229514"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229517"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229468"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229460"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229960"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229585"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229881"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229524"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229885"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229485"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229955"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229640"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229621"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229740"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229451"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229629"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229928"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229939"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229502"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229667"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229791"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229872"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229589"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229632"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229684"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229947"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229652"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229608"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229690"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229523"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229862"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229682"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229634"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229724"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229836"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229578"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229926"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229970"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229615"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229922"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229892"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229623"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229774"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229825"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229737"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229697"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229890"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229954"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229874"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229484"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229641"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229455"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229649"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229522"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229708"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229571"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229722"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229869"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229924"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229532"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229907"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229458"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229870"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229811"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229717"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229662"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229810"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229969"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229783"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229700"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229678"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229454"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229772"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229940"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229746"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229511"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229806"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229895"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229701"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229554"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229605"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229950"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229763"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229929"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229587"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229594"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229513"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229534"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229850"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229548"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229904"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229538"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229644"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229613"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229775"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229910"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229710"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229912"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229597"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229592"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229545"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229637"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229489"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229643"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229550"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229664"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229672"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229909"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229830"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229658"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229889"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229784"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229790"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229618"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229723"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229847"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229807"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229799"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229935"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229770"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229851"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229505"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229564"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229858"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229656"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229733"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229509"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229816"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229595"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229702"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229797"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229800"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229459"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229575"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229593"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229570"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229934"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229528"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229837"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229506"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229497"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229695"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229537"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229481"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229507"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229751"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229719"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229520"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229817"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229809"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229844"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229519"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229500"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229937"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229730"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229882"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229795"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229462"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229887"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229866"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229835"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229558"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229731"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229759"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229901"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229464"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229833"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229706"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229893"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229883"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229666"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229905"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229848"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229529"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229841"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229688"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229741"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229769"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229941"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229739"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229923"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229624"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229938"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229568"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229566"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229908"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229576"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229604"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229659"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229818"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229567"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229622"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229951"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229913"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229472"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229536"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229625"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229756"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229861"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229813"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229932"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229631"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229920"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229675"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229903"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229579"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229453"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229471"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229663"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229707"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229510"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229495"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229457"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229494"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229692"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229673"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229868"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229827"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229620"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229957"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229725"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229525"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229687"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229726"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229917"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229859"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229694"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229793"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229720"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229898"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229543"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229557"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229466"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229879"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229559"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229487"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229614"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229480"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229610"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229504"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229915"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229952"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229752"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229503"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229832"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229914"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229773"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229556"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229829"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229822"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229803"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229753"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229781"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229826"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229591"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229541"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229757"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229607"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229630"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229802"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229779"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229475"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229491"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229565"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229794"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229586"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229888"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229581"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229447"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229633"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229661"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229650"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229562"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229715"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229713"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229680"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229925"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229927"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229744"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229828"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229944"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229544"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229958"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229900"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229488"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229834"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229572"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229949"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229863"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229768"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229845"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229896"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229721"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229698"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229569"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229878"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229738"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229943"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229583"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229884"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229964"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229919"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229857"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229563"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229461"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229823"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229796"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229718"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229777"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229787"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229476"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229780"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229580"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229671"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229767"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229653"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229735"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229760"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229490"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229498"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229745"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229856"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229685"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229703"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229747"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229691"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229714"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229930"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229906"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229483"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229789"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229474"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229839"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229686"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229852"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229628"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229709"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229677"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229669"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229831"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229477"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229860"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229665"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229842"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229547"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229968"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229956"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229754"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229705"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229788"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229966"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229916"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229867"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229959"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229911"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229582"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229553"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229657"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229792"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229627"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229602"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229584"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229603"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229465"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229654"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229530"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229452"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229762"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229712"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229786"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229886"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229486"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229728"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229750"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229499"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229689"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229766"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229598"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229824"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229512"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229601"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229493"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229555"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229668"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229805"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229533"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229626"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229616"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229808"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229542"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229560"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229590"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229948"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229936"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229749"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229873"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229771"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229729"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229646"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229838"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229962"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229814"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229798"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229716"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229963"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229463"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229552"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229492"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229855"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229496"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229965"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229704"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229865"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229853"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229734"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229612"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229636"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229880"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229651"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229573"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229574"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229478"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229804"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229961"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229635"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229600"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229877"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229508"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229482"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229527"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229782"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229551"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229449"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229821"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229846"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229518"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229843"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229619"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229470"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229764"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229765"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229467"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229696"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229785"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229776"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229526"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229660"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229561"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229599"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229801"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229683"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229681"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229815"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229588"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229755"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229647"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229711"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229693"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229535"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229736"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229670"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229606"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229732"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229840"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229448"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229761"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229648"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229864"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229876"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229596"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229577"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229501"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229609"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229611"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229645"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229676"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229655"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229521"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229699"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229854"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229918"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229849"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229899"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229642"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229515"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229945"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229758"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229902"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229473"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229540"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229469"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229479"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229897"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229812"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229743"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229539"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229748"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229820"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229967"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229933"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229516"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229638"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229727"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229891"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229742"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229549"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229450"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229953"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229894"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229778"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229946"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229921"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229674"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001229617"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>